Literature DB >> 33421264

Invariant natural killer T cells: Not to be ignored in liver disease.

Jian Gan1, Xiao Rong Mao1,2, Su Jun Zheng3, Jun Feng Li1,2,4.   

Abstract

The liver is an important immune organ. Hepatocellular injury can be caused by many factors, which further leads to chronic liver diseases by activating the immune system. Multiple immune cells, such as T lymphocytes, B lymphocytes, natural killer cells (NKs), natural killer T cells (NKTs), and γδT cells, accumulate and participate in the immune regulation of the liver. NKTs are an indispensable component of immune cells in the liver, and invariant natural killer T cells (iNKTs) are the main subpopulation of NKTs. iNKTs activated by glycolipid antigen presented on CD1d secrete a series of cytokines and also act on other immune cells through cell-to-cell contact. Studies on the relationship between iNKTs and liver immunity have provided clues to uncover the pathogenesis of liver diseases and develop a promising strategy for the diagnosis and treatment of liver diseases.
© 2021 Chinese Medical Association Shanghai Branch, Chinese Society of Gastroenterology, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  hepatitis; hepatocellular carcinoma; invariant natural killer T-cells; liver fibrosis; liver injury

Year:  2021        PMID: 33421264     DOI: 10.1111/1751-2980.12968

Source DB:  PubMed          Journal:  J Dig Dis        ISSN: 1751-2972            Impact factor:   2.325


  3 in total

Review 1.  Crosstalk Between Autophagy and Innate Immunity: A Pivotal Role in Hepatic Fibrosis.

Authors:  Li Chen; Desong Kong; Siwei Xia; Feixia Wang; Zhanghao Li; Feng Zhang; Shizhong Zheng
Journal:  Front Pharmacol       Date:  2022-05-17       Impact factor: 5.988

Review 2.  Crosstalk between NK cells and hepatic stellate cells in liver fibrosis (Review).

Authors:  Yang Zhang; Yuan Wu; Wenjuan Shen; Bingyu Wang; Xingxing Yuan
Journal:  Mol Med Rep       Date:  2022-05-04       Impact factor: 3.423

Review 3.  The Agonists of Peroxisome Proliferator-Activated Receptor-γ for Liver Fibrosis.

Authors:  Jingjing Li; Chuanyong Guo; Jianye Wu
Journal:  Drug Des Devel Ther       Date:  2021-06-18       Impact factor: 4.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.